跳至主要内容
临床试验/CTRI/2024/03/063700
CTRI/2024/03/063700尚未招募Unknown

A prospective observational study to identify the incidence of hypersensitivity and silent inactivation of PEG-Asparginase in children with acute lymphoblastic leukemia. - NI

Dr Chetan Dhamne0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Children less than equal to 15 years of age with B-ALL or T-ALL receiving PEG asparaginaseas per ICICLE 2014 or standard of care treatment protocol at TMH.

排除标准

  • 1. Children who have received Asparginase as cytoreductive therapy for hyperleukocytosis will not be eligible for this study.
  • 2. Children who receive native L asparaginase will not be eligible for the study.
  • 3. Children who default treatment during induction of undergo induction death will be taken off study.

研究者

发起方
Dr Chetan Dhamne

相似试验

A study to measure the Peg-Asparaginase (a... | 临床试验